Options for the pharmacotherapy of toxoplasmosis during pregnancy
- 1 August 2001
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 2 (8) , 1269-1274
- https://doi.org/10.1517/14656566.2.8.1269
Abstract
Toxoplasmosis infection during pregnancy can cause stillbirths, severe mental retardations or ocular disorders that can also occur later in life and have a potential to relapse. As the disease is generally asymptomatic, diagnosis relies on serological tests. Primary prevention intends to prevent the infection of the fetus, while secondary prevention aims at reducing the severity of sequelae. Preventive attitudes regarding congenital toxoplasmosis differ according to countries. In Austria and France, a nationwide programme based on the screening of seronegative pregnant women and the treatment of all seroconversions has been implemented. The UK and Norway have rejected such a screening due to the lack of evidence of its efficacy. A review of published studies showed that no randomised controlled trials have been conducted. The only available data come from retrospective studies and are methodologically flawed. The impact of chemotherapy on primary and secondary prevention still needs to be assessed. This l...Keywords
This publication has 15 references indexed in Scilit:
- Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosisPublished by Wolters Kluwer Health ,2001
- Cotrimoxazole for Prenatal Treatment of Congenital Toxoplasmosis?Parasitology Today, 2000
- Prenatal diagnosis of congenital toxoplasmosis: A multicenter evaluation of different diagnostic parametersAmerican Journal of Obstetrics and Gynecology, 1999
- Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancyBMJ, 1999
- Azithromycin for ocular toxoplasmosisBritish Journal of Ophthalmology, 1998
- Risk Factors for Toxoplasma gondii Infection in Pregnancy: Results of a Prospective Case-Control Study in NorwayAmerican Journal of Epidemiology, 1996
- Long-Term Follow-up of Patients with Congenital Ocular ToxoplasmosisNew England Journal of Medicine, 1996
- Effectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeysAntimicrobial Agents and Chemotherapy, 1994
- Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study GroupAntimicrobial Agents and Chemotherapy, 1992
- Fetal toxoplasmosis: Outcome of pregnancy and infant follow-up after in utero treatmentThe Journal of Pediatrics, 1989